Search our site
Search our site

Mr Gianluca Fabiano

Research project: Value of pharmaceutical innovation


My research focuses on the process of pharmaceutical innovation with the aim of investigating the role played by different public and private actors in financing the discovery and the R&D of innovative drugs. 


I am a PhD student at Kingston University and I collaborate in research projects in Health Economics with the Centre for Economic and International Studies (CEIS-EEHTA) of the University of Rome "Tor Vergata" where I obtained a Master Degree in Economics in 2015. Previously, I studied at "Roma Tre" University gaining a Bachelor Degree in Political Economy and at the Universitat Pompeu Fabra (UPF) in Barcelona as part of the Erasmus programme. I also held a placement at Kingston University London as a winner of the Erasmus + Traineeship. Recently I attended a short course in "Decision Analytic Modelling for Economic Evaluation" provided by the University of Glasgow and the "Building a Budget Impact Model: Budget Impact Analysis Training" course organized by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). My research focuses on health economics and I am interested in the study of public policies applied to the health sector.

Areas of research interest

  • Health economics
  • Health technology assessment
  • Economic evaluation
  • Public economics


  • MRes in Management and Business Studies Research, Kingston University London
  • MSc in Economics, University of Rome
  • BSc in Political Economy, University of Roma Tre

Funding or awards received

  • Graduate Teaching Assistant


  • Mennini, F., Marcellusi, A., Fabiano, G., Platini, F., & Bossi, P. (2019). Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer. Head & Neck. doi:10.1002/hed.25481
  • Marcellusi, A., Fabiano, G., Viti, R., Morel, P. C. F., Nicolò, G., Siracusano, A., & Mennini, F. S. (2018). Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis. BMJ open, 8(2), e018359.
  • Ibrahim S., Noikokyris E., Fabiano G., Favato G. (2017), "Manipulation of Profits in Italian Publicly Funded Health Care Trusts", Public Money & Management (In Press).
  • Mennini FS, Fabiano G, Marcellusi A, Sciattella P, Saia M, Cocchio S, Baldo V. (2017) "Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study", Clinical Drug Investigation. 

Conference papers

  • Poster and Oral Presentation: Public-Private Contribution to Biopharmaceutical Discoveries: a Bibliometric Analysis of Basic Research in UK", ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain; Congresso Nazionale SIHTA (Societa' Italiana HTA), Rome, 12 October 2018
  • Poster Presentation: "Human Papilloma Virus in Italy: Cost of Illness and Potential Savings Due to HPV9 Primary Prevention", ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, UK.
  • Oral Presentation: "Economic Impact of Macular Edema Diseases in Italy, a Retrospective study", HTAi 14th Annual Meeting, 17-21 June 2017, Rome, Italy.
  • Poster presentation: "Economic Impact of Macular Edema Diseases in Italy", ISPOR 19th Annual European Congress, 29 October-2 November 2016, Austria Center Vienna, Wien, Austria.
  • Poster Presentation: "Direct and Indirect Costs Associated with Retinal Vascular Diseases in Italy. A Probabilistic Cost of Illness Study", ISPOR 18th Annual European Congress, 7-11 November 2015, MiCo - Milano Congressi Milan, Italy, 
Site menu